GENEO Capital led a funding round in Neftys Pharma.

GENEO Capital, a private equity firm, led a funding round in Neftys Pharma, a medical and non-medical veterinary products wholesaler, with participation from UI Investissement and Crédit Agricole. "I am delighted to welcome new investors to Neftys Pharma's capital, which will enable me to structure the group, build loyalty and attract new talent, and above all seize acquisition opportunities in a highly fragmented European market. I was attracted by the UI Investissement team, which is recognised for its expertise in healthcare and its benevolence towards managers, and by GENEO Capital Entrepreneur, which specialises in assisting small and medium-sized companies, particularly in their international development and in CSR. Crédit Agricole is a long-standing partner and has always supported us in our various development projects. Our project is ambitious, as we want to double in size within 5 years and become a European player to support our partners in their various markets," Diego Mignot, Neftys Pharma President.